Skip to main navigation
Skip to main content
Twitter LinkedIn Email
Ocular Therapeutix
  • About
    • Company
    • Hydrogel Technology
    • Leadership
    • Clinical Trials
    • Contact Us
  • Pipeline
    • Retinal Diseases
      • OTX-TKI (axitinib intravitreal implant)
    • Glaucoma
      • OTX-TIC (travoprost intracameral implant)
    • Dry Eye Disease
      • OTX-CSI (cyclosporine intracanalicular insert)
      • OTX-DED (dexamethasone intracanalicular insert)
  • Products
    • DEXTENZA® (dexamethasone ophthalmic insert)
      • Postsurgical Ocular Inflammation and Pain
      • Ocular Itching Associated with Allergic Conjunctivitis
    • ReSure® Sealant
  • Investors
    Investor Relations
    • Press Releases
    • Events and Presentations
      • Upcoming & Past Events
      • Investor & Corporate Presentations
      • Scientific & Medical Presentations
    • SEC Filings
    • Corporate Governance
      • Board of Directors
      • Committee Composition
    • Stock Information
      • Analyst Coverage
      • Historical Price Lookup
      • Investment Calculator
    • Investor FAQs
    • Information Request
  • Careers
    • Culture and Values
    • Benefits
    • Open Positions
  • Search

IR Contacts

Donald Notman
Chief Financial Officer
E-mail: dnotman@ocutx.com

Westwicke Partners on behalf of Ocular Therapeutix
Christopher F. Brinzey
339.970.2843
E-mail: chris.brinzey@westwicke.com

Shareholder Tools
  • Print
  • E-mail
  • RSS
  • Share
  • Alerts
  • Contact
X
  • Share on:
  • Facebook
  • Twitter
  • LinkedIn

© 2023 Ocular Therapeutix, Inc. All rights reserved. DEXTENZA and ReSure are registered trademarks of Ocular Therapeutix, Inc.     PP-US-OTX-0004-V3

Privacy Policy | Terms of Use

The use of this Site is governed by its Terms of Use. The information contained in this Site is for informational purposes only. It is not a substitute for professional medical advice and should not be used to diagnose or treat any medical or health condition.

The contents of this Site are subject to change without notice. Ocular Therapeutix may modify and/or discontinue operation of all or portions of this Site at any time at its sole discretion without notice, and assumes no responsibility to update this Site. Ocular Therapeutix makes no representations or warranties with respect to the use of this Site or any information obtained herein.